(HealthDay)—For detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in symptomatic patients, unsupervised home midnasal swab collection is comparable to clinician-collected nasopharyngeal swab collection, according to a research letter published online July 22 in JAMA Network Open.
Denise J. McCulloch, M.D., M.P.H., from the University of Washington in Seattle, and colleagues compared unsupervised home self-collected swabs to clinician-collected nasopharyngeal swabs for COVID-19 diagnosis in 185 participants. Participants were recruited from symptomatic outpatients testing positive for SARS-CoV-2 and symptomatic health care workers, who were provided test kits for unsupervised home collection of a midnasal swab.
The researchers found that 22.2 percent of the participants yielded SARS-CoV-2 positive test results via the clinician-collected swab, home self-collected swab, or both. One hundred fifty-eight of the participants were health care workers and 9 percent of these participants tested positive. The sensitivity and specificity of home swabs were 80.0 and 97.9 percent, respectively, compared with clinician swabs. There was a positive correlation seen for cycle thresholds (a semiquantitative measure of viral load) of home swabs with clinician swabs. Sensitivity of home swabs was 95 percent in a sensitivity analysis of all swabs with a cycle threshold less than or equal to 32.
“As societies reopen, expansion of testing is critical for preventing a global resurgence in COVID-19,” the authors write. “Home swab collection has the potential to play a pivotal role in increasing testing access across the broader population.”
Several authors disclosed financial ties to the pharmaceutical industry.
Copyright © 2020 HealthDay. All rights reserved.
Midnasal swab done by patient at home detects SARS-CoV-2 (2020, July 27)
retrieved 28 July 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.